VEGFA and cancer: Although blood vessel growth is an attractive target for anti-cancer treatments1,2, anti-angiogenic therapies that target vascular endothelial growth factor (VEGF) and its receptors (VEGFRs) have demonstrated limited efficacy in numerous tumor types3,4.